Search Results - Ruth He

Refine Results
  1. 1
    Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology

    Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology by Philip Coffin, Aiwu Ruth He

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma

    Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma by Narayanan Sadagopan, Aiwu Ruth He

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Systemic therapy for advanced hepatocellular carcinoma: an update

    Systemic therapy for advanced hepatocellular carcinoma: an update by Jasmin Radhika Desai, Sebastian Ochoa, Petra Prins, Aiwu Ruth He

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Systemic Treatment for Advanced Hepatocellular Carcinoma

    Systemic Treatment for Advanced Hepatocellular Carcinoma by Mohamed Bouattour, Neil Mehta, Aiwu Ruth He, E. Cohen, Jean‐Charles Nault

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Advances in Immunotherapy for Transplant Oncology

    Advances in Immunotherapy for Transplant Oncology by Maen Abdelrahim, Abdullah Esmail, Aiwu Ruth He, Moh’d Khushman, Yaser Rayyan

    Published 2024
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  6. 6
    The Role of Angiogenesis in Hepatocellular Carcinoma

    The Role of Angiogenesis in Hepatocellular Carcinoma by Michael A. Morse, Weijing Sun, Richard D. Kim, Aiwu Ruth He, Paolo Abada, Michelle Mynderse, Richard S. Finn

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion

    Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion by Laura Kulik, Leonardo Gomes da Fonseca, Aiwu Ruth He, Jordi Rimola, Andrea Wilson Woods, York Zöllner, Peter R. Galle

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Liver stem cells and hepatocellular carcinoma

    Liver stem cells and hepatocellular carcinoma by Lopa Mishra, Tanuj Banker, Joseph C. Murray, Stephen W. Byers, Arun Thenappan, Aiwu Ruth He, Kirti Shetty, Lynt B. Johnson, E. Premkumar Reddy

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection

    Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection by Neil J. Shah, Ghassan Al‐Shbool, Matthew Blackburn, Michael R. Cook, Anas Belouali, Stephen V. Liu, Subha Madhavan, Aiwu Ruth He, Michael B. Atkins, Geoffrey T. Gibney, Chul Kim

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

    A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer by Michael J. Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J. Hwang, Brandon G. Smaglo, Sunnie S. Kim, Benjamin A. Weinberg, Louis M. Weiner, John L. Marshall, Jonathan R. Brody

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma

    SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma by Ling Lin, Shuyi Chen, Hua Wang, Bin Gao, Bhaskar Kallakury, Krithika Bhuvaneshwar, Katherine Cahn, Yuriy Gusev, Xue Wang, Yunan Wu, John L. Marshall, Xiuling Zhi, Aiwu Ruth He

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

    A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies by Trivedi, Neel D., Armstrong, Samantha, Wang, Hongkun, Hartley, Marion, Deeken, John, Ruth He, A., Subramaniam, Deepa, Melville, Heather, Albanese, Chris, Marshall, John L., Hwang, Jimmy, Pishvaian, Michael J.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

    The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling by Li Lin, Rupen Amin, G. Ian Gallicano, Eric Glasgow, Wilma Jogunoori, J. Milburn Jessup, Michael Zasloff, John L. Marshall, Kirti Shetty, Lynt B. Johnson, Lopa Mishra, Aiwu Ruth He

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma

    Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma by Avijit Majumdar, Steven A. Curley, Xifeng Wu, Powel H. Brown, Jessica Hwang, Kirti Shetty, Zhi-Xing Yao, Aiwu Ruth He, Shulin Li, Lior H. Katz, Patrizia Farci, Lopa Mishra

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer by Michael J. Pishvaian, Rebecca Slack, Wei Jiang, Aiwu Ruth He, Jimmy J. Hwang, Amy Hankin, Karen Dorsch‐Vogel, Divyesh Kukadiya, Louis M. Weiner, John L. Marshall, Jonathan R. Brody

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer

    Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer by Neil H. Segal, Aiwu Ruth He, Toshihiko Doi, Ronald Levy, Shailender Bhatia, Michael J. Pishvaian, Rossano Cesari, Ying Chen, Craig B. Davis, Bo Huang, Aron D. Thall, Ajay K. Gopal

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC)

    Randomised efficacy and safety results for atezolizumab (Atezo) + bevacizumab (Bev) in patients (pts) with previously untreated, unresectable hepatocellular carcinoma (HCC) by Matthew Man Pok Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P. Hack, Jessica Spahn, B. Liu, Hesham Abdullah, Ruth He, Ki Hoon Lee

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

    A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies by John F. Deeken, Rebecca Slack, Glen J. Weiss, Ramesh K. Ramanathan, Michael J. Pishvaian, Jimmy J. Hwang, Karen Lewandowski, Deepa S. Subramaniam, Aiwu Ruth He, Ion Cotarla, Aquilur Rahman, John L. Marshall

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    βII‐Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin

    βII‐Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin by Xiuling Zhi, Ling Lin, Shaoxian Yang, Krithika Bhuvaneshwar, Hongkun Wang, Yuriy Gusev, Mi‐Hye Lee, Bhaskar Kallakury, Narayan Shivapurkar, Katherine Cahn, Xuefei Tian, John L. Marshall, Stephen W. Byers, Aiwu Ruth He

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma

    Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma by Marie Kate Gurka, Christine M. Kim, Aiwu Ruth He, Aline Charabaty, Nadim Haddad, Jenna Turocy, Lynt B. Johnson, Patrick G. Jackson, Louis M. Weiner, John L. Marshall, Sean P. Collins, Michael J. Pishvaian, Keith Unger

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: